Literature DB >> 22981655

Cholinergic blockade frees fear extinction from its contextual dependency.

Moriel Zelikowsky1, Timothy A Hast, Rebecca Z Bennett, Michael Merjanian, Nathaniel A Nocera, Ravikumar Ponnusamy, Michael S Fanselow.   

Abstract

BACKGROUND: Fears that are maladaptive or inappropriate can be reduced through extinction training. However, extinction is highly context-sensitive, resulting in the renewal of fear after shifts in context and limiting the clinical efficacy of extinction training. Lesion and inactivation studies have shown that the contextualization of extinction depends on the hippocampus. Parallel studies have found that intrahippocampal scopolamine (Scop) blocks contextual fear conditioning. Importantly, this effect was replicated with a noninvasive technique in which a low dose of Scop was administered systemically. We aimed to transfer the effects of this noninvasive approach to block the contextualization of fear extinction.
METHODS: Rats were tone fear conditioned and extinguished under various systemic doses of Scop or the saline vehicle. They were subsequently tested (off drug) for tone fear in a context that was the same (control subjects) or shifted (renewal group) with respect to the extinction context.
RESULTS: The lowest dose of Scop produced a significant attenuation of fear renewal when renewal was tested either in the original training context or a novel context. The drug also slowed the rate of long-term extinction memory formation, which was readily overcome by extending extinction training. Scopolamine only gave this effect when it was administered during but not after extinction training. Higher doses of Scop severely disrupted extinction learning.
CONCLUSIONS: We discovered that disrupting contextual processing during extinction with the cholinergic antagonist Scop blocked subsequent fear renewal. Low doses of Scop might be a clinically promising adjunct to exposure therapy by making extinction more relapse-resistant.
Copyright © 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981655      PMCID: PMC3525775          DOI: 10.1016/j.biopsych.2012.08.006

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  63 in total

1.  Dissociation of within- and between-session extinction of conditioned fear.

Authors:  Wolfgang Plendl; Carsten T Wotjak
Journal:  J Neurosci       Date:  2010-04-07       Impact factor: 6.167

2.  A cholinergic-dependent role for the entorhinal cortex in trace fear conditioning.

Authors:  Frederic Esclassan; Etienne Coutureau; Georges Di Scala; Alain R Marchand
Journal:  J Neurosci       Date:  2009-06-24       Impact factor: 6.167

3.  Preventing the return of fear in humans using reconsolidation update mechanisms.

Authors:  Daniela Schiller; Marie-H Monfils; Candace M Raio; David C Johnson; Joseph E Ledoux; Elizabeth A Phelps
Journal:  Nature       Date:  2009-12-09       Impact factor: 49.962

4.  Beyond extinction: erasing human fear responses and preventing the return of fear.

Authors:  Merel Kindt; Marieke Soeter; Bram Vervliet
Journal:  Nat Neurosci       Date:  2009-02-15       Impact factor: 24.884

5.  From contextual fear to a dynamic view of memory systems.

Authors:  Michael S Fanselow
Journal:  Trends Cogn Sci       Date:  2009-11-24       Impact factor: 20.229

6.  Muscarinic receptors in perirhinal cortex control trace conditioning.

Authors:  Sun Jung Bang; Thomas H Brown
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

7.  Lesions of the entorhinal cortex or fornix disrupt the context-dependence of fear extinction in rats.

Authors:  Jinzhao Ji; Stephen Maren
Journal:  Behav Brain Res       Date:  2008-07-18       Impact factor: 3.332

8.  Safety of double-dose transdermal scopolamine.

Authors:  Ronen Bar; Amnon Gil; Dror Tal
Journal:  Pharmacotherapy       Date:  2009-09       Impact factor: 4.705

9.  The use of an unpleasant sound as the unconditional stimulus in aversive Pavlovian conditioning experiments that involve children and adolescent participants.

Authors:  David L Neumann; Allison M Waters; H Rae Westbury
Journal:  Behav Res Methods       Date:  2008-05

10.  Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories.

Authors:  Marie-H Monfils; Kiriana K Cowansage; Eric Klann; Joseph E LeDoux
Journal:  Science       Date:  2009-04-02       Impact factor: 47.728

View more
  35 in total

1.  Contextual fear conditioning depresses infralimbic excitability.

Authors:  Omar Soler-Cedeño; Emmanuel Cruz; Marangelie Criado-Marrero; James T Porter
Journal:  Neurobiol Learn Mem       Date:  2016-02-06       Impact factor: 2.877

2.  Pair-housing rats does not protect from behavioral consequences of an acute traumatic experience.

Authors:  Jennifer E Tribble; Michael S Fanselow
Journal:  Behav Neurosci       Date:  2019-01-10       Impact factor: 1.912

3.  Cholinergic Modulation of Exposure Disrupts Hippocampal Processes and Augments Extinction: Proof-of-Concept Study With Social Anxiety Disorder.

Authors:  Michelle G Craske; Michael Fanselow; Michael Treanor; Alexander Bystritksy
Journal:  Biol Psychiatry       Date:  2019-04-19       Impact factor: 13.382

Review 4.  Animal models of fear relapse.

Authors:  Travis D Goode; Stephen Maren
Journal:  ILAR J       Date:  2014

Review 5.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

Review 6.  Sex differences in fear extinction.

Authors:  E R Velasco; A Florido; M R Milad; R Andero
Journal:  Neurosci Biobehav Rev       Date:  2019-05-23       Impact factor: 8.989

Review 7.  Cholinergic regulation of fear learning and extinction.

Authors:  Marlene A Wilson; Jim R Fadel
Journal:  J Neurosci Res       Date:  2016-10-05       Impact factor: 4.164

8.  Endogenous in-session cortisol during exposure therapy predicts symptom improvement: Preliminary results from a scopolamine-augmentation trial.

Authors:  Kate R Kuhlman; Michael Treanor; Gabriella Imbriano; Michelle G Craske
Journal:  Psychoneuroendocrinology       Date:  2020-03-20       Impact factor: 4.905

Review 9.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Authors:  Daniela Puzzo; Linda Lee; Agostino Palmeri; Giorgio Calabrese; Ottavio Arancio
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

Review 10.  Induction and Expression of Fear Sensitization Caused by Acute Traumatic Stress.

Authors:  Jennifer N Perusini; Edward M Meyer; Virginia A Long; Vinuta Rau; Nathaniel Nocera; Jacob Avershal; James Maksymetz; Igor Spigelman; Michael S Fanselow
Journal:  Neuropsychopharmacology       Date:  2015-08-06       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.